Cargando…
Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction
BACKGROUND: We assessed the effectiveness of perioperative MAGIC-style chemotherapy in our series focused on the tumor regression grade and survival rate. METHODS: We conducted a retrospective study of 53 patients following a perioperative regimen of epirubicin, cisplatin, and fluorouracil or capeci...
Autores principales: | Mingol, Fernando, Gallego, Javier, Orduña, Albina, Martinez-Blasco, Amparo, Sola-Vera, Javier, Moya, Pedro, Morcillo, Miguel Angel, Ruiz, Juan Antonio, Calpena, Rafael, Lacueva, Francisco-Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440567/ https://www.ncbi.nlm.nih.gov/pubmed/25997454 http://dx.doi.org/10.1186/s12893-015-0054-9 |
Ejemplares similares
-
Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
por: Hsu, Andrew, et al.
Publicado: (2020) -
Short-term postoperative outcomes of gastric adenocarcinoma patients treated with curative intent in low-volume centers
por: Lacueva, Francisco-Javier, et al.
Publicado: (2022) -
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma
por: Sun, Weijing, et al.
Publicado: (2023) -
Radiotherapy for tumors of the stomach and gastroesophageal junction – a review of its role in multimodal therapy
por: Buergy, Daniel, et al.
Publicado: (2012) -
Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)